Welcome visitor Log In - or - Register
(
0 items /
$0.00
)
View Cart
Check Out
four ways
Quick Search:
Pirtobrutinib
Pirtobrutinib (LOXO-305) is an orally active highly selective non-covalent Bruton’s tyrosine kinase (BTK) inhibitor. It inhibits wild-type and mutant BTK (IC50s = 10-100 and <10 nM for wild-type BTK and BTK481S, respectively). Pirtobrutinib is more than 300-fold selective for BTK over 370 other kinases tested and shows no significant inhibition of non-kinase off-targets at 1 μM. Pirtobrutinib causes regression of BTK-dependent lymphoma tumors in mouse xenograft models.
Catalog NO: CT-LOXO305
Synonym: LOXO-305
CAS NO: 2101700-15-4
Mol. Formula: C22H21F4N5O3
MW: 479.4